6WB-18839-20371
2 vaccinations
1 coded response
10 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 986 / WA
- Registered
- 2021-12-03
- Relationship
- Child or adolescent in my care
- Guardian
- C5E-98438-44617
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-10
Dose 1 — Pfizer-BioNTech
-
2021-12-01
Dose 2 — Pfizer-BioNTech
-
2021-12-03
Registered in v-safe
-
2021-12-04
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain · Nausea, Vomiting, Diarrhea, Abdominal painAdult check-in
- 2021-12-05
- 2021-12-07
- 2021-12-08
- 2021-12-31
- 2022-01-05
- 2022-01-14
- 2022-03-02
-
2022-06-03
Survey response — 6 months, dose 2, dependentMedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activitiesFree text: Common cold symptoms; tested negative for SARS-CoV-2 via home antigen test.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-10 | Pfizer-BioNTech | No |
| 2 | 2021-12-01 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 2, dependent
Symptoms: Common cold symptoms; tested negative for SARS-CoV-2 via home antigen test.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release